Ticker > Company >

RPG Life Sciences share price

RPG Life Sciences Ltd.

NSE: RPGLIFE BSE: 532983 SECTOR: Pharmaceuticals & Drugs  61k   240   28

2339.50
0 0
BSE: 13 Jun 04:01 PM

Price Summary

Today's High

₹ 2372

Today's Low

₹ 2197.45

52 Week High

₹ 2976.7

52 Week Low

₹ 1457

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

3869.3 Cr.

Enterprise Value

3832.83 Cr.

No. of Shares

1.65 Cr.

P/E

21.12

P/B

7.29

Face Value

₹ 8

Div. Yield

1.03 %

Book Value (TTM)

₹  320.78

CASH

36.47 Cr.

DEBT

0 Cr.

Promoter Holding

72.95 %

EPS (TTM)

₹  110.79

Sales Growth

13.5%

ROE

25.69 %

ROCE

34.96%

Profit Growth

29.6 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of RPG Life Sciences Ltd.

Lomotil Lomofen Naprosyn Azoran Aldactone and Serenace Minmin Tonic Romilast Tricaine Sildura

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year13.5%
3 Year14.36%
5 Year12.01%

Profit Growth

1 Year29.6%
3 Year29.89%
5 Year51.98%

ROE%

1 Year25.69%
3 Year23.84%
5 Year21.81%

ROCE %

1 Year34.96%
3 Year33.11%
5 Year29.39%

Debt/Equity

0

Price to Cash Flow

41.01

Interest Cover Ratio

82.8333

CFO/PAT (5 Yr. Avg.)

1.29943072627724

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 72.95 0.00
Dec 2024 72.95 0.00
Sep 2024 72.81 0.00
Jun 2024 72.81 0.00
Mar 2024 72.81 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 29.8914280870675% for the Past 3 years.
  • The company has significantly decreased its debt by 0.01 Cr.
  • Company has been maintaining healthy ROE of 23.8352655739556% over the past 3 years.
  • Company has been maintaining healthy ROCE of 33.1112574526717% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 82.8333.
  • Company’s PEG ratio is 0.713432458327347.
  • The company has an efficient Cash Conversion Cycle of -64.9162 days.
  • Company has a healthy liquidity position with current ratio of 2.2762.
  • The company has a good cash flow management; CFO/PAT stands at 1.29943072627724.
  • The company has a high promoter holding of 72.95%.

 Limitations

  • The company has shown a poor revenue growth of 14.3626534908383% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 126.99 165.42 172.21 172.71 143.09
Total Expenditure 106.27 126.35 126.28 123.55 117.6
Operating Profit 20.72 39.07 45.93 49.16 25.49
Other Income 1.65 2.37 1.94 3.31 5.06
Interest 0.14 0.15 0.17 0.12 0.18
Depreciation 4.49 5.29 5.31 5.46 5.37
Exceptional Items 0 0 -27.3 0 109.9
Profit Before Tax 17.74 36 15.09 46.89 134.9
Tax 4.5 9.24 10.89 11.96 17.55
Profit After Tax 13.24 26.76 4.2 34.93 117.35
Adjusted EPS (Rs) 8.01 16.18 2.54 21.12 70.96

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 375.57 389.14 440.16 512.81 582.05
Total Expenditure 315.67 318.37 353 409.28 452.91
Operating Profit 59.9 70.77 87.16 103.53 129.14
Other Income 0.99 1.07 3.08 4.8 7.21
Interest 2.76 1.79 1.41 1.15 1.44
Depreciation 16.36 16.47 15.66 15.5 17.07
Exceptional Items -5.32 0 0 0 0
Profit Before Tax 36.45 53.58 73.17 91.68 117.84
Tax 7.44 13.58 21.69 24.04 30.18
Net Profit 29.01 40 51.48 67.64 87.66
Adjusted EPS (Rs.) 17.54 24.19 31.13 40.9 53.01

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 13.23 13.23 13.23 13.23 13.23
Total Reserves 163.34 203.22 242.54 294.37 361.62
Borrowings 1.52 0.74 0.3 0 0
Other N/C liabilities 7.23 6.45 8.43 8.97 6.48
Current liabilities 82.59 79.69 80.11 102.78 130.96
Total Liabilities 267.91 303.33 344.61 419.35 512.29
Assets
Net Block 122.89 113.3 103.71 124.26 113.53
Capital WIP 7.28 9.44 25.45 15.03 84.78
Intangible WIP 2.7 2.33 5.61 10.41 11.53
Investments 0 0 0 0 1.01
Loans & Advances 9.26 2.41 2.93 5.6 3.35
Other N/C Assets 0 0 0 0 0
Current Assets 125.78 175.85 206.91 264.05 298.09
Total Assets 267.91 303.33 344.61 419.35 512.29
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 36.45 53.58 73.17 91.68 117.84
Adjustment 22.52 16.55 13.54 13.31 12.92
Changes in Assets & Liabilities -2.37 -3.53 -3.11 11.06 -7.09
Tax Paid -6.43 -8.33 -18.85 -25.23 -29.31
Operating Cash Flow 50.17 58.27 64.75 90.82 94.36
Investing Cash Flow -10.7 -7.96 -34.66 -105.81 -79.15
Financing Cash Flow -39.3 -10.49 -13.51 -17.12 -20.31
Net Cash Flow 0.17 39.82 16.58 -32.11 -5.1

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 72.81 72.81 72.81 72.95 72.95
carniwal investments limi... - - - - 0.04
ektara enterprises llp 15.57 15.57 15.57 15.57 15.57
harsh vardhan goenka 0.16 0.16 0.16 0.16 0.16
mala goenka 0.05 0.05 0.05 0.05 0.05
nucleus life trust (mr. h... 53.80 53.80 53.80 53.94 53.94
stel holdings limited 3.18 3.18 3.18 3.18 3.18
carniwal investments ltd 0.04 0.04 0.04 0.04 -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 27.19 27.19 27.19 27.05 27.05
authum investment and inf... 2.02 2.02 2.02 2.02 2.02
investor education and pr... 1.03 - 1.03 1.10 1.10
mirae asset multicap fund... 1.42 1.58 1.58 1.15 1.12
quant mutual fund - quant... - - - 1.99 1.98
llp 0.08 0.08 0.08 0.08 -
investor education and pr... - 1.03 - - -

Annual Reports

Title Action
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY ACTION
Credit ICRA
Credit ICRA
TYPE AGENCY ACTION
Research BOB Capital Market
Research BOB Capital Market
Research HDFC Securities
Research BOB Capital Market
Research BOB Capital Market

Concalls & Presentations

TYPE QUARTER ACTION
Concall Q2FY24
TYPE QUARTER ACTION
Presentation Q4FY24
Presentation Q4FY23
Presentation Q4FY22
Presentation Q4FY21
Presentation Q3FY24
Presentation Q2FY24
Presentation Q1FY23

Company News

RPG Life Sciences Stock Price Analysis and Quick Research Report. Is RPG Life Sciences an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into RPG Life Sciences and its performance over the period of time. RPG Life Sciences stock price today is Rs 2341.5.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. RPG Life Sciences cash from the operating activity was Rs 94.36 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. RPG Life Sciences has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In RPG Life Sciences , the EPS growth was 29.5978 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, RPG Life Sciences has OPM of 22.1870973284082 % which is a good sign for profitability.
     
  • ROE: RPG Life Sciences have a healthy ROE of 25.6898 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of RPG Life Sciences is Rs 2341.5. One can use valuation calculators of ticker to know if RPG Life Sciences share price is undervalued or overvalued.
Last Updated on:
Brief about RPG Life Sciences
X